| Next 10 |
Ad
CODX News and Press Co-Diagnostics Inc.
-
Co-Diagnostics, Inc. to CEO to Deliver Keynote Address at 2023 MarketsandMarkets Conference in London, England PR Newswire SALT LAKE CITY , March 21, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics...
-
2023-03-20 15:16:50 ET Co-Diagnostics ( NASDAQ: CODX ) extended the selloff for the second straight session on Monday as H.C. Wainwright downgraded the COVID-19 test maker and halved its price target, citing lower-than-expected Q4 results. The analyst Yi Chen notes that ...
- Co-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22
Co-Diagnostics, Inc. to Host Booth at 10th Gene Quantification Event in Munich, Germany, March 20-22 PR Newswire Chair of Company's SAB, Dr. Carl Wittwer , to present on at-home PCR testing SALT LAKE CITY , March 17, 2023 /PRNewswire/ -- Co-D...
-
2023-03-16 18:37:05 ET Co-Diagnostics, Inc. (CODX) Q4 2022 Earnings Conference Call March 16, 2023 04:30 PM ET Company Participants Andrew Benson - Head of Investor Relations Dwight Egan - Chairman, President and Chief Executive Officer Brian Brown - Chief Financ...
-
2023-03-16 16:02:11 ET Co-Diagnostics press release ( NASDAQ: CODX ): FY GAAP EPS of -$0.45 misses by $0.54 . Revenue of $34.22M (-65.0% Y/Y) misses by $4.1M . For further details see: Co-Diagnostics GAAP EPS of -$0.45 misses by $0.54, revenue of $34.22M ...
-
Co-Diagnostics, Inc. Reports Full Year 2022 Financial Results PR Newswire Full-year Results Impacted by Lower Demand for COVID-19 Testing Announced Initiation of Clinical Evaluations for Co-Dx PCR Home™ Platform SALT LAKE CITY , March 16, 2023 ...
-
2023-03-16 13:38:32 ET Summary This article covers topics from Christopher Mayer's book "100 Baggers." The book is based on studies by several economists and fund managers who have used strategies to uncover 100X opportunities over time. Many of these discoveries were back-tes...
-
2023-03-15 17:35:44 ET Co-Diagnostics ( NASDAQ: CODX ) is scheduled to announce FY earnings results on Thursday, March 16th, after market close. The consensus EPS Estimate is $0.09 (-92.7% Y/Y) and the consensus Revenue Estimate is $38.32M (-60.9% Y/Y). Over the last 1...
-
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 EARNINGS RELEASE DATE AND WEBCAST PR Newswire SALT LAKE CITY , March 9, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for...
-
Co-Diagnostics, Inc. to Present and Host Booth at TRI-CON in San Diego, CA, March 6-8 PR Newswire SALT LAKE CITY , March 2, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, pat...
Stock Information
Get CODX Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
